|
[1]
|
Raina, R., Krishnappa, V., Blaha, T., et al. (2019) Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiolo-gy, Diagnosis, and Treatment. Therapeutic Apheresis and Dialysis, 23, 4-21. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Song, D., Yu, X.-J., Wang, F.-M., et al. (2015) Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement. American Journal of Reproductive Immunology, 74, 345-356. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
彭雪, 吴钊, 彭冰. 产后溶血性尿毒症综合征诊治进展[J]. 实用妇产科杂志, 2017, 33(8): 579-582.
|
|
[4]
|
Yoshida, Y., Kato, H., Ikeda, Y. and Nangaku, M. (2019) Pathogenesis of Atypical Hemolytic Uremic Syndrome. Journal of Atherosclerosis and Thrombosis, 26, 99-110. [Google Scholar] [CrossRef]
|
|
[5]
|
McCullough, J.W., Renner, B. and Thur-man, J.M. (2013) The Role of the Complement System in Acute Kidney Injury. Seminars in Nephrology, 33, 543-556. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
林矜, 余自华. 补体旁路途径失调非典型溶血尿毒综合征的诊断和治疗[J]. 罕少疾病杂志, 2022, 29(5): 1-5.
|
|
[7]
|
王晨虹. 产后溶血性尿毒症综合征[J]. 中华产科急救电子杂志, 2014, 3(3): 190-192.
|
|
[8]
|
Iannuzzi, M., Siconolfi, P., D’Angelillo, A, et al. (2006) A Post-Partum Hemo-lytic-Uremic-Like-Syndrome in a Patient with Pre-Eclampsia: Description of a Clinical Case. Transfusion and Apheresis Science, 34, 11-14. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Rieger, M., Mannucci, P.M., Kremer Hovinga, J.A, et al. (2005) ADAMTS13 Autoantibodies in Patients with Thrombotic Microangiopathies and Other Immunomediated Diseases. Blood, 106, 1262-1267. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
DeYoung, V., Singh, K. and Kretz, C.A. (2022) Mechanisms of ADAMTS13 Regulation. Journal of Thrombosis and Haemostasis, 20, 2722-2732. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Burwick, R.M., Moyle, K., Java, A. and Gupta, M. (2021) Differentiating Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome and Atypical Hemolytic Uremic Syndrome in the Postpartum Period. Hypertension, 78, 760-768. [Google Scholar] [CrossRef]
|
|
[12]
|
李雪艳, 刘晓巍. 妊娠期急性脂肪肝的研究进展[J]. 中国妇产科临床杂志, 2021, 22(5): 559-560. [Google Scholar] [CrossRef]
|
|
[13]
|
Loirat, C., Fakhouri, F., Ariceta, G., et al. (2016) An International Consensus Approach to the Management of Atypical Hemolytic Uremic Syndrome in Children. Pediatric Nephrology, 31, 15-39. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Legendre, C.M., Licht, C., Muus, P., et al. (2013) Terminal Com-plement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome. The New England Journal of Medicine, 368, 2169-2181. [Google Scholar] [CrossRef]
|
|
[15]
|
Åkesson, A., Martin, M., Blom, A.M., et al. (2021) Clinical Char-acterization and Identification of Rare Genetic Variants in Atypical Hemolytic Uremic Syndrome: A Swedish Retrospec-tive Observational Study. Therapeutic Apheresis and Dialysis, 25, 988-1000. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Tanaka, K., Adams, B., Aris, A.M., et al. (2021) The Long-Acting C5 Inhibitor, Ravulizumab, Is Efficacious and Safe in Pediatric Patients with Atypical Hemolytic Uremic Syndrome Pre-viously Treated with Eculizumab. Pediatric Nephrology, 36, 889-898. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
戴艺萍, 阮一平, 洪富源. 非典型溶血性尿毒症治疗的研究进展[J]. 罕少疾病杂志, 2022, 29(7): 1-4.
|